HALO
#824
Halozyme Therapeutics, Inc. - Common Stock
106.9 2 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.13%
Variación mensual
+28.70%
Variación en los últimos 6 meses
+56.49%
Cambio anual
+60.06%
Cierres anteriores
107.0 6
Open
106.9 2
Mínimo
106.9 2
Máximo
106.9 2
Volumen
163
Financials
2026
Current report, 14 Aug 2026
HALOZYME THERAPEUTICS, INC. current report, 14 August 2026
8-K
Current report, Q3 FY2026
HALOZYME THERAPEUTICS, INC. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
HALOZYME THERAPEUTICS, INC. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
HALOZYME THERAPEUTICS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
HALOZYME THERAPEUTICS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
HALOZYME THERAPEUTICS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
HALOZYME THERAPEUTICS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
HALOZYME THERAPEUTICS, INC. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
HALOZYME THERAPEUTICS, INC. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
HALOZYME THERAPEUTICS, INC. current report, Q1 FY2026
8-K